ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 131,41
0,69%
Dow Jones
39 056,39
0,44%
DAX
18 498,38
0,32%
Brent Oil
83,60
0,89%
Bitcoin
61 723,01
-0,99%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. EXACT Sciences Corporation (EXAS)

  7. EXACT Sciences Corporation (EXAS) Actualités

EXAS

EXACT Sciences (EXAS)

EXACT Sciences Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:EXAS
DateHeureSourceTitreSymboleSociété
08/05/202422h08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EXASEXACT Sciences Corporation
08/05/202422h05Business WireExact Sciences Announces First-Quarter 2024 ResultsNASDAQ:EXASEXACT Sciences Corporation
08/05/202414h29IH Market NewsU.S. Futures Slightly Dip Amid Corporate Earnings and Quiet Economic Calendar, Oil Prices FallNASDAQ:EXASEXACT Sciences Corporation
07/05/202414h00Business WireExact Sciences Demonstrates Continued Scientific Advancement in Colorectal Cancer Screening with Multiple Data Presentations at DDW® 2024NASDAQ:EXASEXACT Sciences Corporation
01/05/202412h00Business WireExact Sciences to Participate in May Investor ConferenceNASDAQ:EXASEXACT Sciences Corporation
15/04/202412h00Business WireExact Sciences Names Aaron Bloomer as New Chief Financial OfficerNASDAQ:EXASEXACT Sciences Corporation
11/04/202412h00Business WireExact Sciences Announces Debt Exchange Transaction and Private Placement of Convertible Senior NotesNASDAQ:EXASEXACT Sciences Corporation
08/04/202418h05Business WireExact Sciences to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR Annual Meeting 2024NASDAQ:EXASEXACT Sciences Corporation
08/04/202412h00Business WireExact Sciences Schedules First Quarter 2024 Earnings CallNASDAQ:EXASEXACT Sciences Corporation
04/04/202412h05Business WireExact Sciences to Provide Mayo Clinic Patients with Individualized Cancer Tumor Information to Inform TreatmentNASDAQ:EXASEXACT Sciences Corporation
28/03/202411h00Business WireExact Sciences Advances Development of Non-Endoscopic Oncoguard® Esophagus Test to Screen for Esophageal Cancer and Pre-CancerNASDAQ:EXASEXACT Sciences Corporation
27/03/202413h05Business WireExact Sciences Named 2024 Gallup Exceptional Workplace Award WinnerNASDAQ:EXASEXACT Sciences Corporation
13/03/202422h03Business WireThe New England Journal of Medicine Publishes Cologuard Plus™ Test Results from Pivotal BLUE-C StudyNASDAQ:EXASEXACT Sciences Corporation
07/03/202413h59Business WireExact Sciences and Basketball Great Jamal Mashburn Encourage Americans 45+ to Have a Game Plan Against Colon CancerNASDAQ:EXASEXACT Sciences Corporation
05/03/202402h42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXASEXACT Sciences Corporation
01/03/202421h53Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXASEXACT Sciences Corporation
26/02/202412h00Business WireExact Sciences to Participate in March Investor ConferenceNASDAQ:EXASEXACT Sciences Corporation
21/02/202423h05Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:EXASEXACT Sciences Corporation
21/02/202422h05Business WireExact Sciences Announces Fourth Quarter 2023 ResultsNASDAQ:EXASEXACT Sciences Corporation
01/02/202412h00Business WireExact Sciences Schedules Fourth Quarter 2023 Earnings CallNASDAQ:EXASEXACT Sciences Corporation
07/01/202422h30PR Newswire (US)Exact Sciences Announces Preliminary Fourth Quarter 2023 ResultsNASDAQ:EXASEXACT Sciences Corporation
02/01/202412h00PR Newswire (US)Exact Sciences to participate in J.P. Morgan Healthcare ConferenceNASDAQ:EXASEXACT Sciences Corporation
07/12/202314h05PR Newswire (US)Exact Sciences Awards Grants to 23 Organizations Focused on Increasing Colorectal Cancer ScreeningsNASDAQ:EXASEXACT Sciences Corporation
01/12/202309h00PR Newswire (US)Exact Sciences Presents Multiple Studies at San Antonio Breast Cancer Symposium Supporting Optimization and Individualization of Therapy for Breast Cancer PatientsNASDAQ:EXASEXACT Sciences Corporation
17/11/202313h10PR Newswire (US)Exact Sciences Files Patent Infringement Lawsuit Against GeneoscopyNASDAQ:EXASEXACT Sciences Corporation
01/11/202322h07Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EXASEXACT Sciences Corporation
01/11/202321h17Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:EXASEXACT Sciences Corporation
01/11/202321h05PR Newswire (US)Exact Sciences Announces Third-Quarter 2023 ResultsNASDAQ:EXASEXACT Sciences Corporation
01/11/202311h00PR Newswire (US)Exact Sciences to participate in November investor conferencesNASDAQ:EXASEXACT Sciences Corporation
22/10/202321h00PR Newswire (US)Next-Generation Cologuard® Test Demonstrates High Sensitivity and Specificity in Pivotal BLUE-C Study, Significantly Outperforming Fecal Immunochemical Testing (FIT) for Cancer and Precancer DetectionNASDAQ:EXASEXACT Sciences Corporation
 Showing the most relevant articles for your search:NASDAQ:EXAS

Dernières Valeurs Consultées

SPI
SP500
S&P 500
EU
AF
Air FranceKLM
NASDAQ
AAPL
Apple
EU
GLE
Societe Generale
EU
EN
Bouygues
COIN
BTCUSD
Bitcoin
EU
DG
Vinci
EU
RNO
Renault
EU
SGO
Cie de SaintGobain
USI
USTECH100
US Tech 100
NYSE
KO
Coca Cola
NYSE
DIS
Walt Disney
COIN
ETHUSD
Ethereum
EU
MC
Lvmh Moet Hennessy Louis...
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés